Tabetha Sundin

Passionate about making a difference in cancer patient through targeted therapies. All opinions expressed on this page are my own.

[David Gandara @drgandara]

Congratulations Charu! So well deserved @IASLC

[Alessandro Russo @Al3ssandroRusso]

Liquid Biopsy (LBx) of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment. Our analysis of a large database further reinforce the clinical utility of early LBx use in pts with suspected lung cancer. @ChristianRolfo @geoff_oxnard @lpasquina

[Ana I. Velázquez Mañana, MD, MSc, FASCO @AnaVManana]

🚨 First day of #LungCancerAwarenessMonth

@ACSNews Updates #LungCancerScreening Guideline removing prior limits on years since quitting #tobacco use and expanding eligibility for LDCT

#LCSM #LungCancer #LungCancerAwareness
@UCSFCancer

[WomenInThoracicSurg @WomenInThoracic]

WTS asks all members and allies/supporters to photograph themselves wearing white for the month of November and to tag @WomenInThoracic #WTSWearsWhiteforLC #LCSM

[Charu Aggarwal, MD, MPH, FASCO @CharuAggarwalMD]

One of the highlights of @myESMO #ESMO23 was being in a room with an amazing group of all 🌟 women advisors- thinking of solutions to close the gap for #WomeninOncology @MLJohnsonMD2 @Daniela_Molena @DrJNaidoo #Onward!

[EU-AFRICA PerMed @EU_AfricaPerMed]

Helena Harnik from @FT3Program explains the experience of #collaborating with #patients taking an ecosystem approach, to improve access to Personalised Medicine #treatments.

#PM #PersonalisedMedicine #patientengagement #collaboration

[Charu Aggarwal, MD, MPH, FASCO @CharuAggarwalMD]

Thrilled that our RCT #TESTING is enrolling!
Funded by @theNCI, this trial will answer an important question about the introduction of "early liquid bx" in NSCLC and patient education via Telehealth #BiomarkerTesting #LCSM #NCT05790460
https://t.co/WXNQsmonah @kate_rendle

[Tabetha Sundin @TabethaSundin]

@CharuAggarwalMD @theNCI @kate_rendle @PC3Innovation @PennCancer @AnilVachani @ASCO @IASLC @PennPrecisMed @PennMedicine @PennMedNews @PennMedEVDCSO Thank you for continually supporting evidence generation on the importance of biomarker testing!

[Christian Rolfo @ChristianRolfo]

Learning from @HillStirSci @CancerResrch on the ctMoniTR project Module 1 on NSCLC, using 5 differ te assays with ddPCR and NGS from 22 clinical trials. A very interesting and important initiative to advance in ctDNA molecular responses in clinical application @isliquidbiopsy

[International Society of Liquid Biopsy @isliquidbiopsy]

Great news! #ISLB has recently launched the 'Journal of Liquid Biopsy', the first open-access publication focused on #liquidbiopsy. We are thrilled to also announce Prof. @UmbertoMalapel1 as Editor-in-Chief.

More at https://t.co/y4aKuhBLFs

@OncologyAdvance @OncoAlert

[Elizabeth McKenna @ElizSMcKenna]

Interested in #LiquidBiopsy in Early-Stage Solid Tumors at #AACR23? Read more on Moving forward liquid biopsy in early #livercancer detection by @ChristianRolfo and @Al3ssandroRusso in @CD_AACR: https://t.co/aUuXkVblT2

[International Lung Cancer Summit @LungSummit]

The @IASLC atlas of molecular testing in #LungCancer is now available 📚

The book outlines current and emerging molecular targets, available assays, reporting of molecular testing results and more, from both a diagnostic and clinical perspective ⬇️

https://t.co/DiyJKeKCYj

[International Society of Liquid Biopsy @isliquidbiopsy]

Attention students from Low & Middle Income Countries! Enhance your skills and expand your network with a FREE one-year membership to #ISLB! Access exclusive resources, insights, and connect with professionals worldwide.

Sign up now at https://t.co/HMuGPpwOPg!

@oncoalert

[Alessandro Russo @Al3ssandroRusso]

Happy to support my great mentor and friend Prof. @ChristianRolfo for the @IASLC Board of Directors for North America. I couldn’t imagine a better candidate for this role! Fingers crossed 🤞

[H. Jack West, MD, FASCO @JackWestMD]

Happy to share editorial by @christine_lovly & me in @JCOOP_ASCO discussing critical need to provide support for oncologists in interpreting biomarker testing; we feel it's a critical shortcoming even if we have tissue & solve TAT. Welcome your thoughts:
https://t.co/WBXetfJQTB

[International Society of Liquid Biopsy @isliquidbiopsy]

📢 Call for Applications

#ISLB is calling for applications for its first Certificate of Advanced Studies in Precision Medicine.

The course offers 6 learning modules, Q&A session and quizzes and other interactive tools.

Apply by 4 May 2023 at https://t.co/7VPEAjjmFr

[Charu Aggarwal, MD, MPH, FASCO @CharuAggarwalMD]

Brainstorming ways to improve #biomarker testing in #NSCLC with a MDT team #NSCLC #PersonalizedTherapy
@drgandara @DrAnnaMcGuire @TabethaSundin

[Charu Aggarwal, MD, MPH, FASCO @CharuAggarwalMD]

There are many gaps associated with #Biomarker Testing in #NSCLC. Striking to see that using commercial and medicare claims data, approximately 64% of potentially eligible pts do not get personalized therapy!

@JCOPO_ASCO
https://t.co/5fMRWTPh9b

[AnnabelleGurwitch @LAGurwitch]

Just ran into friends whose work saves lives, mine included, and how was your day? @ChristianRolfo @MountSinaiNYC Mayien Chau @AstraZeneca #TTLC23 @IASLC

[Susan Galbraith @susanmgalbraith]

My mum wasn’t allowed to study #science from the age of 16 because she was a girl. I feel incredibly proud that, only one generation later, I’ve gotten to where I am today, doing the job I’m doing.